Click to copy
Click to copy

Ultragenyx: 2Q Earnings Snapshot

August 1, 2019

NOVATO, Calif. (AP) _ Ultragenyx Pharmaceutical Inc. (RARE) on Thursday reported a loss of $99.2 million in its second quarter.

On a per-share basis, the Novato, California-based company said it had a loss of $1.72. Losses, adjusted for non-recurring gains, were $1.85 per share.

The results missed Wall Street expectations. The average estimate of nine analysts surveyed by Zacks Investment Research was for a loss of $1.73 per share.

The biotechnology company posted revenue of $24.1 million in the period, exceeding Street forecasts. Eight analysts surveyed by Zacks expected $21.7 million.

Ultragenyx shares have increased 39% since the beginning of the year. In the final minutes of trading on Thursday, shares hit $60.43, a drop of 24% in the last 12 months.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on RARE at https://www.zacks.com/ap/RARE

All contents © copyright 2019 The Associated Press. All rights reserved.